Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Next >>

Post by jomagon Feb 25, 2021 10:01am

92 Views

Post# 32656932

L2

V:ICO Depth by Order @10:00:59

Bid			Ask
Broker	Size	Price	Price	Size	Broker
33 Canaccord	30,000	0.125	0.13	92,500	2 RBC
85 Scotia	20,000	0.125	0.13	100,000	79 CIBC
7 TD Sec	36,000	0.125	0.135	405,000	68 Leede
1 Anonymous	10,000	0.125	0.135	15,000	1 Anonymous
7 TD Sec	75,000	0.125	0.135	250,000	68 Leede
7 TD Sec	12,000	0.125	0.135	500	53 Morgan Stanley
7 TD Sec	55,000	0.125	0.135	70,000	1 Anonymous
85 Scotia	20,000	0.125	0.14	250,000	68 Leede
7 TD Sec	20,000	0.125	0.14	400,000	68 Leede
1 Anonymous	10,000	0.125	0.14	100,000	85 Scotia